{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T21:48:36Z","timestamp":1722894516377},"reference-count":44,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,11,19]],"date-time":"2003-11-19T00:00:00Z","timestamp":1069200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2003,12]]},"abstract":"<jats:p><jats:bold>Summary.\u2002<\/jats:bold> Biphenotypic acute leukaemia with T\u2010lymphoid and myeloid markers is rare and poorly documented. In the Leucemie Aigue Lymphoblastique de l'Adulte (LALA) prospective trial (LALA 94) of treatment for adult acute lymphoblastic leukaemia (ALL), seven patients (0\u00b786%) had T\u2010biphenotypic forms. The clinical and biological characteristics and outcome of these seven patients are reported here. The patients\u2019 median age was 35\u2003years. At diagnosis, all had a tumoural syndrome and five had a mediastinal mass. In all the cases, leukaemic cells expressed myeloid and lymphoid markers. Two patients (28%) entered complete remission (CR) after induction chemotherapy. Four of the five remaining and assessable patients entered CR after designed salvage chemotherapy with mitoxantrone and high\u2010dose cytosine arabinoside. Three patients are currently in CR. Three patients died, from treatment toxicity in two cases and progressive disease in one case. One patient relapsed 6\u2003months after allogeneic bone marrow transplantation and is still alive. Thus, biphenotypic T\u2010acute leukaemia is clinically frequently associated with mediastinal involvement and the response to conventional chemotherapy used in ALL is poor. However, sustained CR can be acheived by salvage chemotherapy combining an intercalating agent with high\u2010dose cytosine arabinoside, as used in acute myeloid leukaemia.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2003.04715.x","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T01:31:14Z","timestamp":1069378274000},"page":"842-849","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Adult T\u2010biphenotypic acute leukaemia: clinical and biological features and outcome"],"prefix":"10.1111","volume":"123","author":[{"given":"M. T.","family":"Rubio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Dhedin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Boucheix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Reman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Boiron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lh\u00e9ritier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Fi\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Vernant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the Leucemie Aigue Lymphoblastique de l'Adulte (LALA) Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,11,19]]},"reference":[{"key":"e_1_2_15_2_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-09-2913"},{"key":"e_1_2_15_3_1","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias","volume":"9","author":"Bene M.C.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_15_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V92.2.596"},{"key":"e_1_2_15_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1976.tb03563.x"},{"key":"e_1_2_15_6_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-103-4-620"},{"key":"e_1_2_15_7_1","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.42.6.567"},{"key":"e_1_2_15_8_1","first-page":"919","article-title":"Lineage commitment in biphenotypic acute leukemia","volume":"7","author":"Buccheri V.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_15_9_1","first-page":"1283","article-title":"Cytogenetic findings in acute biphenotypic leukaemia","volume":"10","author":"Carbonell F.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_15_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01714978"},{"key":"e_1_2_15_11_1","first-page":"419","article-title":"Aberration antigen expression in adult acute myelocytic leukemias","volume":"106","author":"Chen S.S.","year":"1993","journal-title":"Chinese Medical Journal"},{"key":"e_1_2_15_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.2870140114"},{"key":"e_1_2_15_13_1","first-page":"777","article-title":"Myeloid surface antigen\u2010positive acute lymphoblastic leukemia (My+ ALL): immunophenotypic, ultrastructural, cytogenetic, and molecular characteristics","volume":"3","author":"Childs C.C.","year":"1989","journal-title":"Leukemia"},{"key":"e_1_2_15_14_1","first-page":"436","article-title":"Molecular evaluation of the NUP98\/RAP1GDS1 gene frequency in adults with T\u2010acute lymphoblastic leukemia","volume":"86","author":"Cimino G.","year":"2001","journal-title":"Haematologica"},{"key":"e_1_2_15_15_1","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V72.2.579.579","article-title":"Acute myeloid leukemia with T\u2010lymphoid features: a distinct biologic and clinical entity","volume":"72","author":"Cross A.H.","year":"1988","journal-title":"Blood"},{"key":"e_1_2_15_16_1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.V79.3.720.720","article-title":"Correlation of cytogenetic patterns and clinicobiological features in adult acute myeloid leukemia expressing lymphoid markers","volume":"79","author":"Cuneo A.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_15_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2900050305"},{"key":"e_1_2_15_18_1","first-page":"420","article-title":"Morphologic and cytochemical characterization of adult lymphoid leukemias which express myeloid antigen","volume":"2","author":"Davey F.R.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_15_19_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.4833286.x"},{"key":"e_1_2_15_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0704"},{"key":"e_1_2_15_21_1","first-page":"637","article-title":"Review of the incidence and clinical relevance of myeloid antigen\u2010positive acute lymphoblastic leukemia","volume":"5","author":"Drexler H.G.","year":"1991","journal-title":"Leukemia"},{"key":"e_1_2_15_22_1","first-page":"489","article-title":"Acute myeloid leukemias expressing lymphoid\u2010associated antigens: diagnostic incidence and prognostic significance","volume":"7","author":"Drexler H.G.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_15_23_1","first-page":"3135","article-title":"Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome","volume":"87","author":"Groupe Francais de Cytogenetique Hematologique","year":"1996","journal-title":"Blood"},{"key":"e_1_2_15_24_1","first-page":"664","article-title":"Myeloid surface antigen expression in adult acute lymphoblastic leukemia","volume":"4","author":"Guyotat D.","year":"1990","journal-title":"Leukemia"},{"key":"e_1_2_15_25_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-03-0717"},{"key":"e_1_2_15_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3536(05)80204-5"},{"key":"e_1_2_15_27_1","first-page":"225","article-title":"A subset of acute lymphoblastic leukemia with co\u2010expression of myeloid antigens: prevalence and clinical significance","volume":"90","author":"Hsu P.N.","year":"1991","journal-title":"Journal of the Formosan Medical Association"},{"key":"e_1_2_15_28_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880019509009476"},{"key":"e_1_2_15_29_1","first-page":"761","article-title":"Immunophenotypic and immunogenotypic analyses of acute leukemia and lymphoblastic lymphoma expressing myeloid and lymphoid antigens","volume":"40","author":"Kawamura K.","year":"1992","journal-title":"Rinsho Byori"},{"key":"e_1_2_15_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/109.2.211"},{"key":"e_1_2_15_31_1","first-page":"699","article-title":"Outcome of biphenotypic acute leukemia","volume":"84","author":"Killick S.","year":"1999","journal-title":"Haematologica"},{"key":"e_1_2_15_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1992.10.9.1419"},{"key":"e_1_2_15_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19910615)67:12<3081::AID-CNCR2820671224>3.0.CO;2-Y"},{"key":"e_1_2_15_34_1","doi-asserted-by":"publisher","DOI":"10.1002\/stem.5530130414"},{"key":"e_1_2_15_35_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00523.x"},{"key":"e_1_2_15_36_1","first-page":"64","article-title":"Definition of acute biphenotypic leukemia","volume":"82","author":"Matutes E.","year":"1997","journal-title":"Haematologica"},{"key":"e_1_2_15_37_1","first-page":"76","article-title":"Study on the expression of myeloid markers and CD34 antigen in adult acute lymphoblastic leukemia","volume":"20","author":"Mi Y.","year":"1999","journal-title":"Zhonghua Xue Ye Xue Za Zhi"},{"key":"e_1_2_15_38_1","first-page":"261","article-title":"Multi\u2010phenotype leukemia in children. Apropos of 18 cases","volume":"47","author":"Monpoux F.","year":"1990","journal-title":"Arch Fr Pediatr"},{"key":"e_1_2_15_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V78.5.1327.1327"},{"key":"e_1_2_15_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V79.9.2415.2415"},{"key":"e_1_2_15_41_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198704303161802"},{"key":"e_1_2_15_42_1","first-page":"156","article-title":"Intensive therapy in 922 adult patients with acute lymphoblastic leukemia (ALL): analysis of the French\u2013Belgian\u2013Swiss\u2013Australian LALA\u201094 trial","volume":"100","author":"Thomas X.","year":"2002","journal-title":"Blood"},{"key":"e_1_2_15_43_1","first-page":"688","article-title":"Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T\u2010cell antigen positive and B\u2010cell antigen positive AML","volume":"7","author":"Tien H.F.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_15_44_1","first-page":"28","article-title":"Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group","volume":"90","author":"Uckun F.M.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_15_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb02649.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04715.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2003.04715.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2003.04715.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T00:07:11Z","timestamp":1697414831000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2003.04715.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11,19]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["10.1046\/j.1365-2141.2003.04715.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04715.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"type":"print","value":"0007-1048"},{"type":"electronic","value":"1365-2141"}],"subject":[],"published":{"date-parts":[[2003,11,19]]},"assertion":[{"value":"2003-11-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}